Introduction
Retinoic acid (RA), a pleiotropic signaling molecule derived from vitamin A, regulates critical genetic programs that control development and homeostasis, cell proliferation and differentiation, as well as cell death or survival (Clagett-Dame and Knutson, 2011) . This is the basis for the use of RA in cancer therapy (Altucci et al., 2007) . These effects of RA are mediated by specific nuclear receptors, RA receptors (RARs), which consist of three subtypes, a (NR1B1), b (NR1B2) and g (NR1B3) (Germain et al., 2006a, b) . The basics of RARs' structure and function have been recapitulated in several reviews (Laudet and Gronemeyer, 2001; Bastien and Rochette-Egly, 2004; Rochette-Egly and Germain, 2009) . Briefly, RARs are multidomain proteins with a central DNA-binding domain linked to an N-terminal domain (NTD) and a C-terminal ligand-binding domain. Classically, RARs function as ligand-inducible transcriptional regulators, heterodimerized with retinoid X receptors (RXRs). As such they regulate the expression of subsets of target genes involved in cell proliferation and differentiation (Duong and RochetteEgly, 2011; Samarut and Rochette-Egly, 2011) . The basic mechanism for switching on gene transcription by RA relies on the binding of RAR/RXR heterodimers to specific sequence elements located in the promoters of target genes and on ligand-induced conformational changes, which cause the association/dissociation of a complex and ever-growing network of coregulatory proteins (Lefebvre et al., 2005; Rochette-Egly and Germain, 2009) .
In addition to this scenario, recent studies highlighted a novel paradigm in which, in vivo, RA also induces the rapid activation of p38MAPK and of the downstream MSK1 (Alsayed et al., 2001; Gianni et al., 2002; Bruck et al., 2009) . Most importantly, the activation of the p38MAPK/MSK1 pathway proved to be crucial for fine-tuning the expression of RAR-target genes through the phosphorylation of RARs and their coregulators (Gianni et al., 2002 (Gianni et al., , 2006 Bruck et al., 2009) . Most interestingly, the activation of p38MAPK by RA occurs very rapidly (within minutes), suggesting a non-genomic action of RA and RARs, as described for steroid hormone receptors (Losel and Wehling, 2003; Vasudevan and Pfaff, 2008) . Therefore, we aimed at deciphering the underlying mechanism of these rapid nongenomic effects. Here, we showed that a fraction of the cellular RARa pool is present in membrane lipid rafts, which are microdomains of cell membranes enriched not only in cholesterol and sphingolipids but also in signal-transducing molecules, such as flotillins, G proteins-coupled receptors, heterotrimeric G proteins, Rho and Rac GTPases, and their effectors (Pike, 2003; de Laurentiis et al., 2007; Sugawara et al., 2007; Yao et al., 2009) . In lipid rafts, G proteins consist of three subunits a, b and g, and transmit signals to downstream effector molecules such as phospholipase C, proteinkinase C and p38MAPK (Mizuno and Itoh, 2009 ).
We identified G protein alpha Q (Gaq), a member of the Ga group, as a new RARa interacting protein in lipid rafts. Finally, both RARa and Gaq were found to mediate the activation of p38MAPK, with characteristic downstream consequences on the expression of the RAtarget genes and on cell growth.
Results
RA activates p38MAPK through RARa and Gaq P38MAPK was rapidly and transiently activated following RA treatment of several cell lines such as human mammary cancer cells (MCF7 cells), HeLa cells, mouse embryocarcinoma cell lines (F9 cells) and mouse embryonic fibroblasts (MEFs) (Figures 1a-d) . Simultaneously, the upstream Rho-GTPases Rac and Rock were also strongly activated in response to RA ( Figures  1e and f) . Now considerable evidence indicates that RhoGTPases activation involves upstream Gaq that interacts with scaffolding proteins in membranes (Sugawara et al., 2007; Mizuno and Itoh, 2009 ). Therefore, we analyzed whether Gaq is involved in the rapid RAinduced activation of the p38MAPK pathway. With this aim, Gaq was knocked down with specific small interfering RNAs (siRNAs) in MCF7 and HeLa cells. No activation of p38MAPK was observed in both cell lines (Figures 2a and c) , suggesting that the rapid activation of the p38MAPK pathway may be mediated by Gaq. Most interestingly, the activation of p38MAPK was also inhibited upon RARa knockdown in these two cell lines (Figures 2b and c) , suggesting that the rapid activation of the p38MAPK pathway may be mediated by both Gaq and RARa. In line with this, p38MAPK was abrogated in F9 cells knockout for RARa (F9 RARaÀ/À) but not in F9 RARgÀ/À and RARbÀ/À cells ( Figure 1b) . Finally, in MEF knockout for the three RARs, MEF (RARa, b, g)À/À p38MAPK was restored upon re-expression of RARa WT, but not of RARg WT (Figures 1c and d) .
RARa is present with Gaq in membrane lipid rafts
There is increasing evidence that intracellular signaling pathways are orchestrated by specific, highly ordered membrane microdomains termed as 'lipid rafts' (Simons and Toomre, 2000; Pike, 2003) . Indeed, lipid rafts are enriched in a large array of signal transduction components, suggesting that they would be 'signaling centers'. As the rapid activation of p38MAPK by RA involves RARa, we isolated these membrane subfractions in order to investigate whether they contain RARa in addition to the signaling molecules.
MCF7 cells were disrupted and lipid rafts were extracted using a unique technique based on their relative insolubility in certain detergent conditions. Then lipid rafts were isolated by virtue of their high buoyancy when centrifuged on a discontinuous sucrose density gradient (Ostrom and Insel, 2006; Waugh and Hsuan, 2009) (Figure 3a) . Such a technique has the advantage of isolating buoyant rafts with their natural composition. Moreover, protein interactions and functions are maintained. As expected, after centrifugation, a faint light-scattering band, which consists of the buoyant lipid rafts material was visible at the 35% sucrose-5% sucrose interface (Ostrom and Insel, 2006) . Then all sucrose gradient fractions were collected, resolved by SDS-polyacrylamide gel electrophoresis and analyzed by immunoblotting for lipid raft-associated proteins. Fractions 4 and 5, which correspond to buoyant rafts (Ostrom and Insel, 2006) contained flotillin-2, a marker of lipid rafts (Stuermer, 2011) (Figure 3b ). They also contained other proteins that are well known to participate in signaling events, such as Rock-2, PKCd and Gaq, (Figure 3b ), corroborating that these fractions correspond to lipid rafts and are signaling centers. Most interestingly, RARa (and not RARg and RARb) could be detected in the same fractions corresponding to lipid rafts (Figure 3b ). Of note is that the amount of RARa present in lipid rafts was very low compared with the amount of RARa present in the bottom fractions (fractions 8-12), which contain the rest of the cellular material, including the nuclear components. Indeed, in immunofluorescence experiments performed with MCF7 cells, RARa was detected essentially in nuclei (Figure 3d ). However, low levels of RARa were also detected out of nuclei and colocalized with flotillin-2 (Figures 3f and g ). Collectively, these results converge to the conclusion that a small population of RARa is present out of nuclei in membrane lipid rafts.
Then the question is, how RARa (and not RARb nor RARg) is targeted to membranes. Given that the three RAR subtypes depict a very high degree of identity in the sequence of their DNA-binding domains and ligandbinding domains, one can speculate that the NTD might specifically target RARa at the membrane. Therefore, we analyzed whether RARa deleted for this domain (RARaDNTD) was present or not in lipid rafts, taking advantage of the F9 cells re-expressing RARa WT or DNTD in a RARa null background (Rochette-Egly et al., 2000) . Remarkably, in contrast to RARa WT, RARaDNTD could not be detected in lipid rafts isolated from the corresponding rescue F9 cell line, indicating that the NTD would be involved in targeting RARa to membranes. In contrast, RARa deleted from the AF-2 domain (RARaDH12) could be detected in rafts isolated from F9 cells expressing this mutant (Rochette-Egly et al., 2000) (Figure 3h ), validating our conclusions.
RARa interacts with Gaq in vitro and in vivo Given that Gaq proteins colocalize with RARa in lipid rafts and are involved in the activation of the p38MAPK pathway, we investigated whether both proteins can interact with each other. First, the ability of RARa to interact with Gaq was analyzed with the recombinant proteins in in vitro protein-protein interaction and coimmunoprecipitation experiments. Recombinant GST Altogether, these results indicate that RARa can form complexes with Gaq and that these complexes are increased in the presence of RA.
Finally, whether endogenous RARa and Gaq form complexes in vivo in lipid rafts was investigated. High amounts of lipid rafts were prepared from RA-treated MCF7 cells and immunoprecipitated with RARa antibodies. As shown in Figure 4c , Gaq could be detected in RARa immunoprecipitates corroborating that RARa and Gaq belong to a same complex in membrane lipid rafts.
Visualization of endogenous RARa/Gaq complexes, in situ, by proximity ligation Next, in situ proximity ligation assay (PLA) (Soderberg et al., 2006) was used to explore further the endogenous RARa/Gaq complexes. The assay is similar to fluorescence resonance energy transfer and allows the detection of proteins in sufficient proximity (o40 nm). It is based on the use of two primary antibodies raised in different species that recognize the antigens of interest. Then species-specific secondary antibodies, called PLA probes, each with a unique short DNA strand attached to it, are added. When the PLA probes are in close proximity, the DNA strands can be joined through the subsequent addition of a circle-forming DNA oligonucleotide that is amplified by rolling circle amplification using a polymerase. After the amplification reaction, several-hundred fold replication of the DNA circle has occurred, and labeled complementary oligonucleotide probes highlight the product. The resulting high concentration of fluorescence in each single-molecule amplification product is easily visible as a distinct bright spot when viewed under a fluorescence microscope.
Here, rabbit anti-RARa and mouse anti-Gaq antibodies were used under the PLA conditions to explore, in situ, endogenous RARa/Gaq complexes, in MCF7 cells treated with RA for different times. Quite few RARa/Gaq complexes were detected in the control untreated cells (Figures 5b and c) . Considerable higher amounts of complexes were seen in the RA-treated cells with a peak around 10 min (Figures 5e and f) , which corresponds to the peak of p38 MAPK activation. Most interestingly, the signals were out of nuclei. Then the number of spots returned to control values at 30 min (Figures 5h and i) . Spots number was quantified using the Blobfinder V3.2 software (Centre for Image Analysis, Uppsala University, Sweden, http://www.cb.uu.se/Bamin/ BlobFinder/) and the average values±s.d. from at least two experiments are shown (Figure 5j) . No signal was seen Figure 5 Analysis of RARa/Gaq complexes in MCF7 cells by immunofluorescence microscopy in combination with in situ proximity ligation assay (PLA). (a-i) PLA is highly specific for detecting physically interacting protein-protein complexes (red, panels b, e, h). DNA was counterstained with 4,6-diamidino-2-phenyl indole (DAPI) (blue, panels a, d, g). The merge between blue and red is also shown (panels c, f, i). A few RARa/Gaq complexes are shown in control MCF7 cells (b, c). The amount of complexes increased markedly out of nuclei in MCF7 cells treated with RA for 10 min (e, f) and returned to control values at 30 min (h, i). (j) Statistical analysis of the signals using the Blobfinder V3.2 software.
when each primary antibody was used individually, validating the specificity of the technique. Similar results were obtained with several other RA-treated cells such as HeLa cells and MEF (Figure 6 ). Collectively, these results confirm that endogenous RARa is present in a complex with endogenous Gaq out of nuclei, in response to RA.
Note, however, that the increased number of RARa/ Gaq complexes was observed specifically in response to RA. Indeed, the activation of the p38MAPK pathway that occurs in response to epidermal growth factor (EGF) through Gaq proteins (Figure 7a ), does not involve RARa (Figure 7a) . Accordingly, no increase in RARa/Gaq complexes could be observed in response to EGF as assessed in a PLA (Figure 7b ).
In erbB-2 positive breast cancer cells, p38MAPK is not activated in response to RA and RARa does not form complexes with Gaq Then, we asked whether RA-resistant cells exemplified by the human erbB-2 positive breast cancer cells also depict an activation of p38MAPK and the formation of RARa/Gaq complexes in response to RA. First, the erbB-2 positive cells, BT474, SKBR3, MDA-MB453 and MDA-MB361 cells (Tari et al., 2002) (Figure 8a ) were compared with MCF7 cells for p38MAPK activation in response to RA. Remarkably, in these cell lines p38MAPK activation was decreased or abrogated up to 60 min after RA addition (Figure 8b) .
Then, we concentrated on BT474 cells, which depict the highest levels of erbB-2 and are completely defective in p38MAPK activation. Membrane lipid rafts were isolated from these cells and were analyzed by immunoblotting. Both RARa and Gaq could be detected in lipid rafts from these cells (Figure 8c ). However, no RARa/Gaq complexes could be visualized in situ by proximity ligation (Figures 8e-j) , whereas a high amount of complexes were seen in MCF7 cells under the same conditions (Figures 8k-p) . Note that the ability of EGF to activate p38MAPK was also abrogated in BT474 cells (Figure 8d ), though this pathway does not involve the formation of RARa/ Gaq complexes (see Figure 7) . Collectively, these data highlight the importance of the initial formation of RARa/Gaq complexes in lipid rafts for p38MAPK activation in response to RA. They also suggest that the signaling pathways, involving Gaq proteins, are affected in erbB-2 positive cells (see Discussion).
The integrity of the Gaq/p38MAPK pathway is required for the full RA-induction of RARa-target genes and the antiproliferative action of RA According to our previous work, activation of the p38MAPK/MSK1 pathway is significant for the activation of RARa-target genes in several cell lines, including MCF7 cells and MEF (Bruck et al., 2009) . Then, we asked whether upstream Gaq is required for the induction of RA-target genes. In MCF7 cells, RA treatment enhances the expression of the Hoxa-1 and Btg2 genes, which are the paradigm of the RA-target genes as assessed by quantitative real time-PCR. Knockdown of Gaq decreased the RA-induced expression of both genes (Figures 9a and b) . Most interestingly, it also reduced the antiproliferative action of RA (Figure 9c ) in line with other studies (Lai et al., 2008; White et al., 2008) . Of note is that knockdown of the downstream effectors p38MAPK and MSK1 also decreased the RA-induced expression of RA-target genes, though less efficiently than the knockdown of RARa (Figure 8c ), corroborating our previous studies (Bruck et al., 2009) . Collectively, these results highlight the importance of the Gaq/p38MAPK/MSK1 pathway for RAR-target gene expression and growth arrest that occur in response to RA. 
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Discussion
Rapid responses, such as the activation of signaling pathways, are initiated at the plasma membrane in lipid rafts and then amplified by cascades of activation of downstream effectors including G proteins, Rho family small GTPases, phospholipase C, the Src family tyrosine kinases and p38MAPK. As RA activates very rapidly the p38MAPK pathway, we speculated that this effect would be non-genomic and mediated by a membraneassociated RAR. Here, we provide evidence that in various mammalian epithelial and fibroblastic cells, the RARa subtype, which is normally found in the nucleus, is also present in plasma membranes. Moreover, membrane-associated RARa forms complexes with Gaq to generate rapid p38MAPkinase activation in response to RA (see Figure 9e) .
First of all, to find out the mechanism of activation of the p38MAPK pathway by RA, we investigated, which RAR subtype is involved and whether this RAR could be detected in membrane lipid rafts that are 'signaling centers'. Taking advantage of cell lines invalidated for one specific RAR subtype or re-expressing a specific RAR in a triple RAR (a, b, g) null background, we demonstrated that the activation of p38MAPK in response to RA, involves specifically the RARa subtype. However, in immunofluorescence confocal studies, RARa was present essentially in nuclei and was hardly detected in plasma membranes, despite some spots suggesting a colocalization of RARa with flotillin-2, a marker of lipid rafts. In fact, RARa could be detected in detergent-insoluble membrane lipid rafts that are concentrated by sucrose equilibrium density gradients and that are enriched in components of signal transduction pathways (Pike, 2003; de Laurentiis et al., 2007) . RARa was detected in the same low-density buoyant fractions as flotillin and Gaq. The fact that RARa colocalizes with flotillin-2 in lipid rafts is a novelty in the field. It is also in line with the new concept in which most of the classical so-called nuclear steroid and non-steroid receptors (ER, GR, PR, AR, VDR) can be found in specialized plasma membrane structures such as caveolae and lipid rafts (Huhtakangas et al., 2004; Marquez et al., 2006; Pedram et al., 2007; Luoma et al., 2008; Matthews et al., 2008) .
How RARa is recruited to the plasma membrane is still ill-defined. Indeed, in contrast to the other steroid receptors, RARa does not depict any palmitoylation motif that would facilitate its membrane localization (Pedram et al., 2007) . However, according to our results, the N-terminal domain that is not conserved between RARs, appears to be necessary for targetting specifically RARa to lipid rafts. In addition, RARa present in lipid rafts forms complexes with Gaq proteins and the number of these complexes is increased in response to RA. These complexes were seen in vitro with the recombinant proteins by GST pull down and coimmunoprecipitation and were corroborated in vivo, with the endogenous proteins in coimmunoprecipitation experiments performed with enriched lipid rafts. In fact, the originality of the present study resides in the use of a 'PLA', which can reveal transient endogenous protein complexes even when present at very low levels (Soderberg et al., 2006) . Such a technique allowed us to visualize, in situ, a rapid and transient increase (10-15 min after RA addition) in RARa/Gaq complexes. It also revealed that the complexes are out of the nuclei, confirming the hypothesis that the non-genomic effects of RA involve a pool of extra nuclear RARa.
The interesting point is that Gaq is involved with RARa in the activation of p38MAPK (Figure 8d ). This is a novelty in the field of the non-genomic effects of RA and is in agreement with the well-known role of Gaq in the activation of the p38MAPK pathway (Sugawara et al., 2007; White et al., 2008; Mizuno and Itoh, 2009) . It is worth noting that this pathway was activated by RA in epithelial and fibroblastic cells but not in neuronal and sertoli cells, where RA rather activates the p42/p44MAPK (Erk) pathway through Src and PI3K (Pan et al., 2005; Dey et al., 2007; Masia et al., 2007; Chen and Napoli, 2008; Zanotto-Filho et al., 2008) . Thus, the mechanism of the non-genomic effects of RA appears to involve different membrane-associated complexes, depending on the MAPK pathway that is RA-activated and on the cell type. Similarly, the nongenomic effects of the other nuclear receptors involve different kinases and different membrane molecular complexes, depending on their functional significance (Losel and Wehling, 2003; Norman et al., 2004) . As an example, in breast cancer cells and in response to its cognate ligand, the estrogen receptor ERa activates the Erk pathway through complexes containing c-Src and the regulatory subunit of PI3K (p85a) (Migliaccio et al., 1998; Le Romancer et al., 2008) . In contrast, in neuronal cells, ER rather activates protein kinase C through Gaq and phospholipase C (Qiu et al., 2003) . In the same line of idea, depending on the cell type, VDR activates either the RhoA-Rock-p38MAPK pathway (Ordonez-Moran et al., 2008) or the Raf/Erk pathway (Norman et al., 2001; Losel and Wehling, 2003) .
The present study also corroborates the new concept, according to which the non-genomic effects of RA influence the genomic effects (Rochette-Egly and Germain, 2009; Piskunov and Rochette-Egly, 2011) . Indeed, our results indicate that the knockdown of Gaq and its downstream effectors, p38MAPK and MSK1, decreases the expression of RAR-target genes. The modes of interaction between the non-genomic and genomic effects of RA are complex, but according to other studies from our laboratory, the downstream effectors of the non-genomic effects, p38MAPK and MSK1, phosphorylate the actors of the genomic action of RA, that is, histones, RARs and their coregulators such as SRC-3 (Gianni et al., 2002 (Gianni et al., , 2006 Bruck et al., 2009) . As such, the RA-induced phosphorylation cascades control protein-protein and DNA-protein interactions, and the dynamics of transcription. Thus, one can conclude that the non-genomic effects of RA cross talk with the genomic processes for assuming the specificity of RAR-target genes expression.
Finally, our results highlight that in RA-resistant breast cancer cells characterized by aberrant receptor tyrosine kinase expression and/or activity (exemplified by erbB-2 breast cancers), the formation of RARa/Gaq complexes is suppressed, resulting in the abrogation of the nongenomic effects of RA, that is, the activation of p38MAPK. Remarkably, other signaling pathways involving Gaq proteins, such as the EGF pathway, are also affected in such cells. It is important to note that most signaling pathways are controlled by essential scaffolding proteins of lipid rafts such as caveolin-1 (Sugawara et al., 2007; Staubach and Hanisch, 2011) . Moreover, caveolin-1 is frequently downregulated in erbB-2 positive cells (Park et al., 2005) . Therefore, one can speculate that the integrity of lipid rafts composition would be required for the formation of Gaq-based complexes including RARa/Gaq complexes, and thereby for the activation of the signaling pathways. Whether there is a correlation between these observations and the resistance of such cancer cells to the antiproliferative action of RA would require further investigations, but is out of the scope of this study. Nevertheless, our results and others (Lai et al., 2008; White et al., 2008; Staubach and Hanisch, 2011) suggest that Gaq proteins, as well as several components of lipid rafts, would have an important role in the control of not only gene expression but also cell growth.
Materials and methods

Plasmids, antibodies and reagents
The pSG5-based expression vector for RARa and the prokaryotic pGEX-2T vector encoding RARa fused to GST were previously described (Bour et al., 2005) . The pcDNA3.1 Gaq vectors (WT and constitutively active) were purchased from Missouri S&T cDNA Resource Center (Rolla, MO, USA).
Mouse monoclonal antibodies (Ab10a (A) and Ab9a(F)) as well as rabbit polyclonal antibodies (RPa(F)) raised against RARa were described earlier (Gaub et al., 1992) . Rabbit polyclonal antibodies against PKCd (C-17), goat polyclonal antibodies against b-actin (C-11) and Rock-2 as well as mouse monoclonal antibodies against Gaq and Flotillin-2 were obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). The rabbit polyclonal antibodies against RARa (C-20), used in the immunofluorescence experiments were also from Santa Cruz. Antibodies against p38 MAPK, phospho-p38 MAPK (Thr180/Tyr182) and HER2/ErbB2 antibodies were purchased from Cell Signalling Technology (Danvers, MA, USA). Rabbit polyclonal antibodies against GAPDH were from Sigma Aldrich Chemie (Saint Quentin Fallavier, France), as well as all trans RA and epidermal growth factor (EGF).
Cell culture, proliferation, transfections and immunoprecipitations MCF7, BT474, SKBR3, MDA-MB453, MDA-MB361 and HeLa cells were cultured under standard conditions. MEFs with all three RARs deleted and re-expressing RARa WT or RARg WT were previously described (Bruck et al., 2009) . Mouse embryocarcinoma cells (F9 cells), WT, RARaÀ/À, RARgÀ/À and RARbÀ/À, were previously described (Taneja et al., 1997; Faria et al., 1999) , as well as F9 cells re-expressing RARa, WT, DNTD and DAF-2 in a RARa null background (RochetteEgly et al., 2000) . COS-1 cells were transiently transfected using the FuGENE 6 reagent (Roche, Meylan, France) according to the manufacturer's protocol. When they have reached 80-90% confluency, cells were treated with RA (10 À7 M) or EGF (100 ng/ ml), after 24 h in a medium containing 1% fetal calf serum (Bruck et al., 2009) . Extracts were prepared, immunoblotted or immunoprecipitated as described (Bruck et al., 2009) .
Cell proliferation was analyzed by using the XTT (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay kit according to the manufacturer's instructions (Roche Diagnostics).
Detection of active p38MAPK, Rac1 and Rock2 Phosphorylated p38MAPK was detected by using a phospho p38MAPK (Thr (P)-180/Tyr (P)-182) ELISA kit (Biosource Invitrogen Corporation). Where indicated it was also analyzed by immunoblotting with antibodies recognizing specifically the active phosphorylated form of p38MAPK. Activation of Rho family GTPases was analyzed using the Rac1,Rac 3 and 3 G-LISA Rac activation assay Biochem Kit (Cytoskeleton, Denver, CO, USA), and the Rock activity assay kit (Cell Biolabs, San Diego, CA, USA).
GST pull-down assays Equimolar amounts of GST and GST-fusion proteins expressed in Escherichia coli were purified on glutathione-sepharose 4B beads (Amersham Biosciences, GE Healthcare Europe GmbH, Branch France, Velizy-Villacoublay, France) and incubated as previously described (Bour et al., 2005) , with in vitro-translated Gaq produced in Quick Coupled Transcription/Translation System (Promega, Charbonnie`res les Bains, France).
Small interfering RNA
The ON-TARGET plus SMART pool siRNA against human Gaq (M-008562-00-0005), human RARa (L-003437-00-0005), human p38MAPKa (L-003512-00), human MSK1 (M-004665-01) and the control non-targeting siRNA pool (D-001206-13) were purchased from Dharmacon (Thermo Fisher Scientific, Illkirch, France). Cells were transfected with siRNAs (50 nM) according to the manufacturer's protocol and treated with RA (10 À7 M) 48h post-transfection. Then at the indicated times, the cells were harvested and subjected to RNA and protein analysis.
Rafts Isolation
Membrane lipid rafts were isolated using the procedure described in Ostrom and Insel (2006) and Waugh and Hsuan (2009) . Briefly, 6 Â 10 7 cells grown in petri dishes were washed twice in phosphate-buffered saline and then lyzed for 1 min on ice in 1 ml of 10 mM Tris-HCl (pH 7.4) containing 1% (v/v) Triton X-100, 1 mM EDTA, 0.5 mM ethylene glycol tetraacetic acid and protease/phosphatase inhibitors. Then the cell lysate was scrapped, transferred to a 2-ml Dounce homogenizer and homogenized with 10 strokes on ice. The lysate was adjusted to 2 ml and an equal volume of 80% sucrose was added. The two solutions were then mixed thoroughly by pipetting up and down several times to give a final concentration of 40% sucrose in a 4-ml volume. Then 4 ml of 30% sucrose and 4 ml of 5% sucrose were layered carefully. After centrifugation at 240 000 Â g for 16 h at 4 1C, samples were collected from the top of the tube as 1-ml fractions (12 fractions in total). Fractions were analyzed by SDS-polyacrylamide gel electrophoresis and immunoblotting. A faint light-scattering band, which consists of the buoyant lipid rafts material, was often visible at the 35%-5% sucrose interface (fractions 4 and 5).
For further immunoprecipitation of rafts proteins, rafts were prepared from 2 Â 10 8 cells. After sucrose gradient centrifugation, fractions corresponding to rafts were collected, centrifuged (100 000 Â g for 1 h at 4 1C) and the final pellet was resuspended in immunoprecipitation buffer.
Immunofluorescence Cells grown on coverslips were fixed in 4% paraformaldehyde -phosphate-buffered saline for 20 min, permeabilized with 0.5% Triton X-100 and blocked with 1% bovine serum albumin in phosphate-buffered saline for 30 min. Then the cells were incubated with the primary antibodies, followed by ALEXAFluor 448 or 555 conjugated secondary antibodies (Invitrogen, Villebon sur Yvette, France). Nuclei were counterstained with 4,6-diamidino-2-phenyl indole (SigmaAldrich Chimie). Cells were analyzed by fluorescence microscopy using a LEICA DMRX microscope (LEICA Microsystems, Rueil Malmaison, France) equipped with a LEICA True Confocal Scanner TCS SP. The used objective was Leica HCX PL APO 63 Â 1.40 LBL.
Proximity ligation assay (PLA) Cells were grown on coverslips, fixed, permeabilized, blocked and incubated with primary antibodies (anti-RARa and anti Gaq), as described for immunofluorescence experiments. Duolink II (Eurogentec, Angers, France) in situ PLA was performed according to the manufacturer's protocol. PLA probes were incubated for 1 h at 37 1C, followed by hybridization, ligation, amplification and detection. Nuclei were counterstained with 4,6-diamidino-2-phenyl indole. Slides were analyzed by fluorescence microscopy using a LEICA DM4000B microscope (LEICA Microsystems) equipped with a Cool SNAP photometric camera. The used objective was Leica HCX PLAN APO 40x0, 75 PH 2. The number of fluorescent signals and nuclei in an image were counted, and were statistically analyzed using the Blobfinder V3.2 software from the Centre for Image Analysis at Uppsala University (http://www.cb.uu.se/Bamin/BlobFinder/). Statistical significance was accepted when Po0.05 using one-tailed Student t test. Values are presented as means±s.d.
RNA isolation and quantitative real time-PCR
Total RNAs were isolated and subjected to quantitative real time-PCR as described (Bruck et al., 2009) . All primers are QuantiTect Primer Assays from Qiagen (Courtaboeuf, France, Hs_BTG2_1_SG QuantiTect Primer Assay QT00240247; Hs_HOXA1_1_SG QuantiTect Primer Assay QT00011963). Transcript levels were normalized according to b-actin transcripts, which are unresponsive to RA.
